In Situ Formation of Fibronectin‐Enriched Protein Corona on Epigenetic Nanocarrier for Enhanced Synthetic Lethal Therapy
Abstract
Research context
OpenAlex topics: PARP inhibition in cancer therapy · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Center for Pharmacogenetics Department of Pharmaceutical Science University of Pittsburgh School of Pharmacy Pittsburgh PA 15213 USA
Department of Pharmacy and Therapeutics University of Pittsburgh School of Pharmacy Pittsburgh PA 15213 USA
Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center University of Pittsburgh School of Pharmacy Pittsburgh PA 15213 USA
Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center Omaha NE 68106 USA
Fred & Pamela Buffett Cancer Center University of Nebraska Medical Center Omaha NE 68106 USA
Funding
National Institutes of Health